Biotheryx, Inc., a biopharmaceutical company focused on the discovery and development of first-in-class protein degraders for cancer and inflammatory diseases, today announced the data from its ...
Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial ...
Verekitug led to statistically significant and clinically meaningful improvement in asthma symptom control as measured by the ...
Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...
Company rapidly advancing Phase 3 programs designed to deliver best-in-class efficacy with convenient quarterly dosing in ...
Data reinforce WVE-006’s potential to address both lung and liver manifestations of AATD with a durable, convenient, and safe ...
Vietnam Investment Review on MSN
Harbour BioMed announces promising preclinical data for its first ai enabled drug candidate
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, May 18, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and ...
The aggregate value of the Am Law 100 surpassed $400 billion for the first time in CFO Madhav Srinivasan's latest effort at ...
The Himachal Pradesh Board of School Education (HPBOSE), Dharamshala, is set to declare the Class 10 (Matric) Annual ...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, May 17, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to th ...
Biogen’s Apellis acquisition consolidates a complement franchise spanning retinal and renal indications, with near-term label ...
Today's applications require monitoring, logging, configuration, etc. Each of these concerns can be implemented as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results